文献速递系统性红斑狼疮

儿童起病系统性红斑狼疮达标治疗达成情况及预测因素分析

Treat-to-target achievement and predictive analysis in childhood-onset systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该单中心回顾性研究纳入97例未治疗儿童起病SLE患者,中位随访2.6年,评估cLLDAS、DORIS、cCR等达标情况。结果显示cLLDAS和cCR在真实临床实践中可达,但维持稳定具有挑战性。

要点

  • 97例患者中cLLDAS达标70/97(72.16%),DORIS达标64/90(65.98%),cCR达标41/97(42.27%)。
  • 达到LLDAS、cLLDAS、DORIS、cCR的中位时间分别为1.22、1.44、1.49、1.52年。
  • 维持LLDAS/cLLDAS/DORIS/cCR超过随访一半时间的比例分别为40.21%、30.93%、23.71%、19.59%。

核心结论

  • cLLDAS和cCR在真实临床实践中是可实现的目标,但维持两种状态的稳定性仍极具挑战性。

研究设计与样本

  • 单中心回顾性应用cLLDAS和缓解定义于前瞻性收集的真实世界cSLE队列数据,纳入97例未治疗患者,中位随访2.6年。
  • 疾病活动度采用SLEDAI-2K和PGA评估。

主要发现

  • 75/97(77.32%)达到LLDAS,70/97(72.16%)达到cLLDAS,64/90(65.98%)达到DORIS,41/97(42.27%)达到cCR。
  • 达到LLDAS、cLLDAS、DORIS、cCR的中位时间分别为1.22、1.44、1.49、1.52年。
  • 维持LLDAS-50、cLLDAS-50、DORIS-50、cCR-50的比例分别为40.21%、30.93%、23.71%、19.59%。
  • 男性患者更早达到cLLDAS和DORIS;初诊时病程较长是达到cLLDAS和cCR的积极因素;糖皮质激素冲击治疗是达到cLLDAS和DORIS时间的负面预测因素。
  • 更早首次达到cLLDAS或cCR与更高概率达到cLLDAS-50和cCR-50相关。

临床怎么用

  • 原文未报告临床实践推荐。

局限性

  • 原文自述为单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to validate the achievement of treat-to-target (T2T) in childhood-onset SLE (cSLE) at Wuhan Children's Hospital. METHOD: This study involved a retrospective application of the childhood-onset lupus low disease activity state (cLLDAS) and remission definitions to prospectively gathered data from a real-world cSLE cohort. Disease activity was evaluated using the SLEDAI 2000 (SLEDAI-2K) and Physician Global Assessment (PGA). RESULT: Ninety-seven untreated patients were included in the study, with a median follow-up of 2.6 years. Among them, 75 (77.32%), 70/97 (72.16%), 64/90 (65.98%) and 41/97 (42.27%) patients achieved lupus low disease activity state (LLDAS), childhood-onset lupus disease activity state (cLLDAS), Definitions of Remission in SLE (DORIS) and childhood-onset clinical remission (cCR), respectively. The median times to achieve these targets were 1.22, 1.44, 1.49 and 1.52 years, respectively. The proportions of patients who maintained stability in LLDAS, cLLDAS, DORIS and cCR for over half of the follow-up period (LLDAS/cLLDAS/DORIS/cCR-50) were 40.21%, 30.93%, 23.71% and 19.59%, respectively. Male patients achieved cLLDAS and DORIS earlier. A longer disease duration at initial diagnosis was a positive factor for achieving cLLDAS and cCR. In contrast, glucocorticoid (GC) pulse therapy was a negative predictor for time to cLLDAS and DORIS. Earlier achievement of the first cLLDAS or cCR was associated with a higher probability of reaching cLLDAS-50 and cCR-50. CONCLUSION: This single-centre study demonstrates that cLLDAS and cCR are achievable targets in real-life clinical practice. However, maintaining stability in both states remains highly challenging. These findings highlight the need for optimized treatment strategies to improve long-term disease control and outcomes in cSLE, especially for lighter or younger cSLE patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yin W, Lin Y, Wang S, et al. Treat-to-target achievement and predictive analysis in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford). 2026. PMID: 41289145. doi:10.1093/rheumatology/keaf620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。